Sweden · Delayed Price · Currency is SEK MedCap AB Statistics
Total Valuation
MedCap AB has a market cap or net worth of SEK 7.25 billion. The enterprise value is 7.37 billion.
| Market Cap | 7.25B |
| Enterprise Value | 7.37B |
Important Dates
The next confirmed earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedCap AB has 15.02 million shares outstanding. The number of shares has increased by 1.20% in one year.
| Current Share Class | 15.02M |
| Shares Outstanding | 15.02M |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 37.75% |
| Float | 11.87M |
Valuation Ratios
The trailing PE ratio is 32.92 and the forward PE ratio is 26.38.
| PE Ratio | 32.92 |
| Forward PE | 26.38 |
| PS Ratio | 3.44 |
| PB Ratio | 4.97 |
| P/TBV Ratio | 21.71 |
| P/FCF Ratio | 22.87 |
| P/OCF Ratio | 21.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.50, with an EV/FCF ratio of 23.25.
| EV / Earnings | 33.53 |
| EV / Sales | 3.49 |
| EV / EBITDA | 17.50 |
| EV / EBIT | 25.53 |
| EV / FCF | 23.25 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.33.
| Current Ratio | 2.01 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.15 |
| Debt / FCF | 1.52 |
| Interest Coverage | 9.17 |
Financial Efficiency
Return on equity (ROE) is 16.07% and return on invested capital (ROIC) is 13.77%.
| Return on Equity (ROE) | 16.07% |
| Return on Assets (ROA) | 7.85% |
| Return on Invested Capital (ROIC) | 13.77% |
| Return on Capital Employed (ROCE) | 13.67% |
| Weighted Average Cost of Capital (WACC) | 6.91% |
| Revenue Per Employee | 3.31M |
| Profits Per Employee | 345,055 |
| Employee Count | 627 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 3.23 |
Taxes
In the past 12 months, MedCap AB has paid 68.30 million in taxes.
| Income Tax | 68.30M |
| Effective Tax Rate | 23.63% |
Stock Price Statistics
The stock price has increased by +40.25% in the last 52 weeks. The beta is 0.51, so MedCap AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +40.25% |
| 50-Day Moving Average | 481.09 |
| 200-Day Moving Average | 547.50 |
| Relative Strength Index (RSI) | 59.93 |
| Average Volume (20 Days) | 12,915 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedCap AB had revenue of SEK 2.11 billion and earned 219.80 million in profits. Earnings per share was 14.67.
| Revenue | 2.11B |
| Gross Profit | 1.24B |
| Operating Income | 288.70M |
| Pretax Income | 289.00M |
| Net Income | 219.80M |
| EBITDA | 377.20M |
| EBIT | 288.70M |
| Earnings Per Share (EPS) | 14.67 |
Balance Sheet
The company has 370.40 million in cash and 482.90 million in debt, with a net cash position of -112.50 million or -7.49 per share.
| Cash & Cash Equivalents | 370.40M |
| Total Debt | 482.90M |
| Net Cash | -112.50M |
| Net Cash Per Share | -7.49 |
| Equity (Book Value) | 1.46B |
| Book Value Per Share | 96.68 |
| Working Capital | 497.10M |
Cash Flow
In the last 12 months, operating cash flow was 342.70 million and capital expenditures -25.70 million, giving a free cash flow of 317.00 million.
| Operating Cash Flow | 342.70M |
| Capital Expenditures | -25.70M |
| Depreciation & Amortization | 153.30M |
| Net Borrowing | 48.20M |
| Free Cash Flow | 317.00M |
| FCF Per Share | 21.11 |
Margins
Gross margin is 58.67%, with operating and profit margins of 13.69% and 10.42%.
| Gross Margin | 58.67% |
| Operating Margin | 13.69% |
| Pretax Margin | 13.70% |
| Profit Margin | 10.42% |
| EBITDA Margin | 17.88% |
| EBIT Margin | 13.69% |
| FCF Margin | 15.03% |
Dividends & Yields
MedCap AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.20% |
| Shareholder Yield | -1.20% |
| Earnings Yield | 3.03% |
| FCF Yield | 4.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
MedCap AB has an Altman Z-Score of 5.85 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.85 |
| Piotroski F-Score | 5 |